PROFOUND MEDICAL CORP (PROF) Stock Analyst Earnings Estimates
NASDAQ:PROF - Nasdaq - CA74319B5027 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.681M -2.79% | 7.199M 7.75% | 10.68M 48.35% | 18.281M 71.17% | 42.824M 134.25% | 58.277M 36.08% | 124.57M 113.75% | 181.15M 45.42% | 253.2M 39.77% | 321.64M 27.03% | 398.97M 24.04% | |
| EBITDA YoY % growth | -27.998M 1.46% | -27.47M 1.89% | -32.126M -16.95% | -38.555M -20.01% | -28.482M 26.13% | -10.676M 62.52% | 29.06M 372.21% | 59.779M 105.71% | 105.08M 75.78% | 138.3M 31.61% | 175.55M 26.93% | |
| EBIT YoY % growth | -29.602M 2.27% | -28.616M 3.33% | -33.062M -15.54% | -40.35M -22.04% | -28.533M 29.29% | -30.805M -7.96% | 40.747M 232.27% | 9.432M -76.85% | 32.464M 244.19% | N/A | N/A | |
| Operating Margin | -443.08% | -397.50% | -309.57% | -220.72% | -66.63% | -52.86% | 32.71% | 5.21% | 12.82% | N/A | N/A | |
| EPS YoY % growth | -1.38 8.00% | -1.35 2.17% | -1.12 17.04% | -1.12 -0.10% | -0.87 22.07% | -1.15 -31.79% | 0.66 157.04% | 1.38 110.83% | 2.47 78.07% | 3.25 31.99% | 4.14 27.31% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.37 -32.56% | -0.37 1.66% | -0.17 14.15% |
| Revenue Q2Q % growth | 3.568M 59.79% | 4.823M 70.30% | 11.918M 185.32% |
| EBITDA Q2Q % growth | -10.769M -46.36% | -10.689M -28.79% | 2.727M 136.81% |
| EBIT Q2Q % growth | -11.346M -44.68% | -11.11M -23.47% | -5.353M 35.85% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.36 -38.46% | -0.28 | -0.08 | -27.30% |
| Q4 2024 Q2Q % growth | -0.20 52.38% | -0.35 | 0.15 | 42.88% |
| Q3 2024 Q2Q % growth | -0.38 -46.15% | -0.30 | -0.08 | -28.63% |
| Q2 2024 Q2Q % growth | -0.28 20.00% | -0.29 | 0.01 | 5.06% |
| Q1 2024 Q2Q % growth | -0.26 18.75% | -0.28 | 0.02 | 6.39% |
| Q4 2023 Q2Q % growth | -0.42 8.70% | -0.32 | -0.10 | -30.15% |
| Q3 2023 Q2Q % growth | -0.26 -8.33% | -0.34 | 0.08 | 23.48% |
| Q2 2023 Q2Q % growth | -0.35 -25.00% | -0.36 | 0.01 | 2.34% |
| Q1 2023 Q2Q % growth | -0.32 20.00% | -0.36 | 0.04 | 11.99% |
| Q4 2022 Q2Q % growth | -0.46 6.12% | -0.37 | -0.09 | -23.09% |
| Q3 2022 Q2Q % growth | -0.24 17.24% | -0.37 | 0.13 | 35.19% |
| Q2 2022 Q2Q % growth | -0.28 20.00% | -0.40 | 0.12 | 29.52% |
| Q1 2022 Q2Q % growth | -0.40 -8.11% | -0.46 | 0.06 | 13.90% |
| Q4 2021 Q2Q % growth | -0.49 -28.94% | -0.34 | -0.15 | -45.55% |
| Q3 2021 Q2Q % growth | -0.29 10.17% | -0.27 | -0.02 | -8.35% |
| Q2 2021 Q2Q % growth | -0.35 -5.43% | -0.29 | -0.06 | -20.88% |
| Q1 2021 Q2Q % growth | -0.37 -98.84% | -0.27 | -0.10 | -39.15% |
| Q4 2020 Q2Q % growth | -0.38 -11.44% | -0.31 | -0.07 | -24.05% |
| Q3 2020 Q2Q % growth | -0.32 25.23% | -0.25 | -0.08 | -31.30% |
| Q2 2020 Q2Q % growth | -0.33 11.19% | -0.22 | -0.11 | -48.16% |
| Q1 2020 Q2Q % growth | -0.19 17.54% | -0.26 | 0.08 | 29.29% |
| Q4 2019 Q2Q % growth | -0.34 | -0.49 | 0.15 | 31.00% |
| Q3 2019 Q2Q % growth | -0.43 | -0.39 | -0.04 | -11.34% |
| Q2 2019 Q2Q % growth | -0.37 | -0.34 | -0.03 | -10.00% |
| Q1 2019 Q2Q % growth | -0.23 | -0.34 | 0.11 | 33.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 2.621M 37.23% | 3.535M | -914K | -25.86% |
| Q4 2024 Q2Q % growth | 4.177M 107.91% | 4.309M | -132K | -3.06% |
| Q3 2024 Q2Q % growth | 2.832M 63.89% | 2.91M | -78K | -2.68% |
| Q2 2024 Q2Q % growth | 2.233M 39.39% | 2.417M | -184K | -7.61% |
| Q1 2024 Q2Q % growth | 1.91M 2.69% | 2.82M | -910K | -32.27% |
| Q4 2023 Q2Q % growth | 2.009M 59.82% | 1.997M | 12K | 0.60% |
| Q3 2023 Q2Q % growth | 1.728M -15.09% | 2.087M | -359K | -17.20% |
| Q2 2023 Q2Q % growth | 1.602M -20.89% | 2.158M | -556K | -25.76% |
| Q1 2023 Q2Q % growth | 1.86M 36.36% | 2.238M | -378K | -16.89% |
| Q4 2022 Q2Q % growth | 1.257M 25.95% | 2.962M | -1.705M | -57.56% |
| Q3 2022 Q2Q % growth | 2.035M -19.79% | 2.224M | -189K | -8.50% |
| Q2 2022 Q2Q % growth | 2.025M -22.92% | 1.818M | 207K | 11.39% |
| Q1 2022 Q2Q % growth | 1.364M 91.84% | 2.19M | -826K | -37.72% |
| Q4 2021 Q2Q % growth | 998K -65.34% | 2.592M | -1.594M | -61.50% |
| Q3 2021 Q2Q % growth | 2.537M 13.36% | 3.886M | -1.349M | -34.71% |
| Q2 2021 Q2Q % growth | 2.627M 156.04% | 2.236M | 391K | 17.49% |
| Q1 2021 Q2Q % growth | 711K -38.71% | 2.612M | -1.901M | -72.78% |
| Q4 2020 Q2Q % growth | 2.879M 35.98% | 2.271M | 608.4K | 26.79% |
| Q3 2020 Q2Q % growth | 2.238M 333.05% | 1.837M | 401K | 21.83% |
| Q2 2020 Q2Q % growth | 1.026M 138.99% | 749.309K | 276.691K | 36.93% |
| Q1 2020 Q2Q % growth | 1.16M 4.47% | 882.023K | 277.977K | 31.52% |
| Q4 2019 Q2Q % growth | 2.118M | 2.073M | 44.5K | 2.15% |
| Q3 2019 Q2Q % growth | 516.8K | 1.179M | -662.2K | -56.17% |
| Q2 2019 Q2Q % growth | 429.3K | 983.316K | -554.016K | -56.34% |
| Q1 2019 Q2Q % growth | 1.11M | 780.972K | 329.428K | 42.18% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -10.25% | -31.25% | 0% | 0% |
| Revenue | -12.4% | -13.84% | 0% | 0% |